Tetraphase Pharmaceu
(TTPH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Sales | 1,243 | 1,962 | 2,471 | 2,856 | 3,343 |
| Gross Profit | 1,243 | 1,962 | 2,471 | 2,856 | 3,343 |
| Operating Expenses | 18,505 | 18,776 | 20,603 | 20,909 | 29,396 |
| Operating Income | -17,262 | -16,814 | -18,132 | -18,053 | -26,053 |
| Other Income | 94 | 73 | 16 | 9 | 10 |
| Pre-tax Income | -17,168 | -16,741 | -18,116 | -18,044 | -26,043 |
| Net Income Continuous | -17,168 | -16,741 | -18,116 | -18,044 | -26,043 |
| Net Income | $-17,168 | $-16,741 | $-18,116 | $-18,044 | $-26,043 |
| EPS Basic Total Ops | -9.40 | -9.20 | -9.80 | -9.80 | -14.40 |
| EPS Basic Continuous Ops | -9.37 | -9.15 | -9.68 | -9.90 | -14.39 |
| EPS Diluted Total Ops | -9.40 | -9.20 | -9.80 | -9.80 | -14.40 |
| EPS Diluted Continuous Ops | -9.37 | -9.15 | -9.68 | -9.90 | -14.39 |
| EBITDA(a) | $-17,193 | $-16,747 | $-18,069 | $-17,988 | $-26,019 |